Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00744354 · TERMINATED
Trial details
- NCT number
- NCT00744354
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2011-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.